This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Matrix Pharma deal receives gun-jumping fine in India for unauthorized changes

By Freny Patel ( April 2, 2025, 08:15 GMT | Insight) -- Matrix Pharma and associated parties have been fined by the Competition Commission of India for "gun-jumping" after making unauthorized changes to a previously approved acquisition structure. The CCI noted the changes were made without prior notification, violating the 2002 Competition Act. Matrix Pharma and associated parties have been fined for "gun-jumping" by the Indian antitrust watchdog, following unauthorized changes to a previously approved acquisition structure....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login